Novartis Pursues Internal Development While Seeking External Opportunities

Novartis is using a combination of its own internal development, in-licensing deal and acquisitions to bolster its pipeline. Novartis Head of Pharma Development James Shannon recently spoke with "The Pink Sheet" DAILY to discuss the company's development priorities.